Detecting uterine cancer early is vital because it is highly treatable in its initial stages. While symptoms like abnormal bleeding often prompt early diagnosis, not all women exhibit warning signs. Regular screenings and awareness of the symptoms of uterine cancer in women, such as unusual bleeding or pelvic pain, play a key role in identifying the disease promptly.
Women who experience the following symptoms or conditions should consult a healthcare provider:
Those with risk factors, including obesity, a family history of uterine cancer, or conditions such as endometrial hyperplasia, are at a higher likelihood of developing this disease.
The gynecologist examines the uterus and ovaries for any abnormalities or masses. This is typically the initial step in evaluating symptoms.
An ultrasound provides detailed images of the uterus and pelvic organs. It helps identify unusual thickening in the endometrial lining, a potential indicator of cancer.
This procedure involves removing a small tissue sample from the uterine lining to check for cancer cells. It’s often performed in the doctor’s office and is a definitive method for diagnosis.
A D&C is sometimes conducted to collect a larger tissue sample for testing.
This involves using a small camera to inspect the uterine lining for abnormalities and guide biopsy procedures.
If cancer is suspected to have spread, imaging tests help determine the extent of the disease.
Treatment options depend on the stage, grade, and overall health of the patient:
LifePlus Hospital offers comprehensive care for uterine cancer patients:
Our experienced gynecologic oncologists, surgeons, and radiologists specialize in treating uterine cancer.
We use state-of-the-art diagnostic and treatment tools to ensure optimal outcomes.
Each patient receives a tailored plan, addressing their unique needs and preferences.
From diagnosis to recovery, we provide emotional, psychological, and medical support to guide patients through their journey.
Early detection of uterine cancer can significantly improve treatment outcomes. The key to early detection is paying attention to warning signs, particularly abnormal vaginal bleeding. Women who experience unusual bleeding or spotting after menopause should see a doctor immediately. In some cases, imaging tests or a biopsy can detect cancer before symptoms become severe.
While there is no standard screening test for uterine cancer, women who have a higher risk (due to family history, obesity, or other factors) may benefit from more frequent monitoring or early detection strategies. If you have a high risk, your doctor may recommend:
Regular transvaginal ultrasounds to monitor the endometrial lining.
Periodic endometrial biopsies if there is concern about thickening of the uterine lining.
Regular gynaecological exams to assess any potential symptoms.
If you have a genetic predisposition (such as Lynch syndrome), genetic counselling and testing may also be recommended.
Women with a family history of uterine cancer, especially those with a known genetic condition like Lynch syndrome, should discuss more personalized screening options with their healthcare provider. These women may be at higher risk and may benefit from closer monitoring, including:
A transvaginal ultrasound is typically used to measure the thickness of the uterine lining (endometrium). A thickened endometrial lining can sometimes be a sign of endometrial cancer, especially in postmenopausal women. However, other conditions, like polyps or endometrial hyperplasia, can also cause thickening. If the lining is found to be thicker than normal, further tests, such as an endometrial biopsy, may be recommended.
Women should seek medical attention if they experience:
These symptoms do not necessarily indicate cancer but should be evaluated by a doctor to rule out uterine cancer or other conditions.
The survival rate for uterine cancer largely depends on the stage at diagnosis. When detected early (stage I), the 5-year survival rate is high, often exceeding 90%. However, if the cancer has spread beyond the uterus (to lymph nodes or distant organs), the survival rate is lower. The overall 5-year survival rate for uterine cancer is approximately 81%.
While uterine cancer cannot be entirely prevented, there are steps that may lower the risk:
There is no fixed schedule for uterine cancer screening for most women. However, women who are at higher risk should follow their doctor’s recommendations for more frequent screening or check-ups. If you have risk factors or if you're experiencing symptoms, regular check-ups and screenings (such as pelvic exams, ultrasounds, or biopsies) may be necessary.